搜索临床试验以:capecitabine camrelizumab apatinib
总计4197个结果
-
Lei Li招聘中宫颈癌 | 免疫疗法 | 生存结果 | 不良事件 | 局部晚期宫颈癌 | 放化疗 | 免疫检查点抑制剂 | 抗程序性细胞死亡受体 1 | Early Stage Cervical Cancer中国
-
Augusta UniversityH. Jean Khoury Cure CML Consortium招聘中
-
Wei ZhaoCancer Institute and Hospital, Chinese Academy of Medical Sciences未知
-
Sun Yat-sen UniversityChengdu Biostar Pharmaceuticals尚未招聘
-
UNC Lineberger Comprehensive Cancer CenterNovartis Pharmaceuticals完全的
-
Peking University People's HospitalPeking University Shougang Hospital; Peking University International Hospital撤销
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.完全的
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
Sichuan Cancer Hospital and Research InstituteJiangsu HengRui Medicine Co., Ltd.完全的
-
Wei JiangWuzhou Red Cross Hospital; Laibin People's Hospital; Guangxi Naxishan Hospital; People's Hospital...完全的
-
Yue HanJiangsu HengRui Medicine Co., Ltd.招聘中
-
Second Affiliated Hospital, School of Medicine,...尚未招聘
-
Chinese PLA General Hospital未知
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu Hengrui Pharmaceutical Co., Ltd.未知
-
National Cancer Institute (NCI)主动,不招人转移性胰腺癌 | 复发性胰腺癌 | III 期胰腺癌 AJCC v6 和 v7 | IV 期胰腺癌 AJCC v6 和 v7美国
-
Hunan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.招聘中
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.邀请报名
-
Jiangsu HengRui Medicine Co., Ltd.主动,不招人
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
Herbert Hurwitz, MDBristol-Myers Squibb完全的
-
Peking University People's HospitalPeking University Shougang Hospital; Peking University International Hospital完全的
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
University of Southern CaliforniaNational Cancer Institute (NCI)终止
-
AbbVie主动,不招人高眼压症 | 开角型青光眼美国, 阿根廷, 澳大利亚, 保加利亚, 捷克语, 丹麦, 德国, 匈牙利, 爱尔兰, 意大利, 新西兰, 波兰, 俄罗斯联邦, 南非, 瑞典, 英国
-
Binghe XuHoffmann-La Roche未知
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中